← board
ORGO
Organogenesisdistress 0/10 · well-funded / low risk$2.44-1%today-63% from 52w high
Pain 1
Lead: knee osteoarthritis
Revenue
$37M
Liquidity
$91M
Runway
—
Shares 1y
+1%
Price & events
-39.0% over 6M
CatalystRating changeDilutionFinancingdashed = today
-1.2%
1D
-8.6%
1W
+0.5%
1M
+4.8%
3M
-37.7%
6M
-51.0%
1Y
-23.0%
2Y
-83.7%
5Y
-68.9%
All
Overview
- Market Cap
- $314.13M
- Volume
- 40.84K
- 52 Week Range
- $2.24 – $6.54
- Total Shares
- 128.67M
- Float Shares
- 57.38M
- Short %
- 16.87%
- % Held by Insiders
- 47.46%
- % Held by Institutions
- 49.56%
- RVOL
- 0.05x
- Beta
- 1.33
Pipeline stages · 1 programs
Amniotic Suspension Allograft, Placebo
Preclin›
Ph1›
Ph2›
Ph3›
Filed›
PDUFA›
Approved
Pipeline · 1 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| 2025-08-15 | Phase 3 | Amniotic Suspension Allograft, Placebo | Knee Osteoarthritis | 594 | completed |
Catalyst news & presentations · 2
- 2026-08-06Estimated 45%earningsEarningsEarnings releaseyahoo
- by the end of October 2025regulatory submissionFiled (NDA/BLA)ReNu · Request pre-BLA meeting with FDA to discuss submission pathway including combined efficacy analysisSEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
hold · target $3 (+23% upside) · 1 analysts
- 2026-05-28Truist SecuritiesHold
- 2026-03-26BTIGBuy
- 2026-02-27BTIGBuy
- 2025-12-26BTIGBuy
- 2025-12-15BTIGBuy
- 2025-11-20BTIGBuy
Recent news
- 2026-07-23Organogenesis Holdings (ORGO) Slides 7.8% as Stock Tests Key Support Zone - IV Expansion Alert - dars.gov.et
- 2026-07-19Organogenesis Holdings (ORGO) Slips 1.87% as Resistance Holds; Key Levels in Focus - Breakout Stock Alerts - dars.gov.et
- 2026-07-18ORGO Q1 2026 Earnings: Significant EPS Miss Sends Shares Lower - Book Value Growth - dars.gov.et
- 2026-07-17Organogenesis stock trades steadily as wound care margins support outlook - Ad-hoc-news.de
- 2026-07-16Organogenesis Holdings (ORGO) Surges 7.23% as Stock Finds Traction Above Support - Hot Stock Picks - dars.gov.et
- 2026-07-13ORGO Q1 2026 Earnings: EPS Miss by Significant Margin, Stock Declines - Revenue Beat Analysis - DonanımHaber
- 2026-07-13ORGO Q1 2026 Earnings: EPS Miss by Significant Margin, Stock Declines - Quarterly Profit Report - dars.gov.et
- 2026-07-10Organogenesis (ORGO) AGM 2026 Summary - Quartr
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.